Document Detail

Cardioprotective effect of Azadirachta indica A. Juss. on isoprenaline induced myocardial infarction in rats.
MedLine Citation:
PMID:  17467089     Owner:  NLM     Status:  MEDLINE    
The present study was designed to evaluate the cardioprotective potential of aqueous leaf extract of Azadirachta indica A. Juss. (AI) on the basis of haemodynamic, biochemical and histopathological parameters in isoprenaline induced myocardial infarction in rats and to compare with vitamin E, a known cardioprotective antioxidant. A significant (p<0.01) decrease in mean arterial blood pressure (MAP), systolic arterial blood pressure (SAP), diastolic arterial blood pressure (DAP) and increase in heart rate (HR) were observed in isoprenaline control group. Isoprenaline showed significant decrease in the level of cardiac marker enzymes [Lactate dehydrogenase (LDH) and Serum Glutamate Oxalotransaminase (SGOT)] in the heart homogenate with a corresponding increase in their level in serum. In vitamin E control group significant (p<0.05) increase in LDH in heart homogenate and decrease of SGOT and LDH in serum was observed. In isoprenaline control group, significant (p<0.01) increase in total cholesterol and triglycerides levels while decrease in high-density lipoproteins (HDL) was observed. On histopathological examination, myocardial damage in isoprenaline control group further confirmed cardiotoxic effect of isoprenaline. Our data showed that AI (250, 500 and 1000 mg/kg, p.o.) and vitamin E (100 mg/kg, p.o.) significantly restores most of the haemodynamic, biochemical and histopathalogical parameters. Finally we concluded that AI leaf extract exerts equipotent cardioprotective activity in the experimental model of isoprenalin induced myocardial necrosis in rats as compared to vitamin E, a known cardioprotective antioxidant.
Prashee A Peer; Purvi C Trivedi; Prashant B Nigade; Mahesh M Ghaisas; Avinash D Deshpande
Related Documents :
17481639 - Azelnidipine has anti-atherosclerotic effects independent of its blood pressure-lowerin...
22783319 - Effects of continuous intermedin infusion on blood pressure and hemodynamic function in...
3405529 - What should be done about hypercholesterolaemia?
19913849 - Angiopoietin-2 levels in glucose intolerance, hypertension, and metabolic syndrome in a...
12048129 - Urinary albumin excretion is related to cardiovascular risk indicators, not to flow-med...
12476929 - Decreased large artery distensibility in borderline hypertension is related to increase...
239609 - The effect of artifical ventilation and dehydrobenzperidol on the development of early ...
21221599 - Uncontrolled home blood pressure in the morning is associated with nephropathy in japan...
22449049 - The structure of the phloem - still more questions than answers.
Publication Detail:
Type:  Comparative Study; Letter     Date:  2007-04-27
Journal Detail:
Title:  International journal of cardiology     Volume:  126     ISSN:  1874-1754     ISO Abbreviation:  Int. J. Cardiol.     Publication Date:  2008 May 
Date Detail:
Created Date:  2008-04-21     Completed Date:  2008-09-15     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8200291     Medline TA:  Int J Cardiol     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  123-6     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Cardiotonic Agents / therapeutic use*
Isoproterenol / toxicity*
Myocardial Infarction / chemically induced,  metabolism,  pathology,  prevention & control*
Plant Extracts / therapeutic use
Plant Leaves
Rats, Wistar
Reg. No./Substance:
0/Cardiotonic Agents; 0/Plant Extracts; 7683-59-2/Isoproterenol

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Coronary stent fracture in a saphenous vein graft to right coronary artery--successful treatment by ...
Next Document:  A practical method for subtyping of Streptococcus agalactiae serotype III, of human origin, using ro...